Page last updated: 2024-11-06

new methylene blue

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

New methylene blue (NMB) is a thiazine dye with a long history of clinical use as an antidote for cyanide poisoning. It is also being investigated for its potential therapeutic effects in a variety of conditions, including Alzheimer's disease, stroke, and cancer. NMB is synthesized by reacting methylene blue with a strong reducing agent, such as sodium dithionite. NMB is a potent redox-active molecule that can scavenge reactive oxygen species and modulate cellular signaling pathways. The mechanism of action of NMB is complex and likely involves multiple targets. In addition to its antioxidant properties, NMB has also been shown to inhibit the aggregation of amyloid-beta peptides, a key pathological feature of Alzheimer's disease. NMB has a favorable safety profile and is well-tolerated by patients. However, further research is needed to fully elucidate its therapeutic potential.'

Cross-References

ID SourceID
PubMed CID73518
SCHEMBL ID220238
MeSH IDM0107980

Synonyms (26)

Synonym
sigma b-4631
unii-5gcz112bcn
c.i. basic blue 24 (van)
3,7-bis(ethylamino)-2,8-dimethylphenothiazin-5-ium chloride
nsc 9605
5gcz112bcn ,
einecs 217-696-9
nsc9605
c.i. basic blue 24
new methylene blue
methylene blue nn
phenothiazin-5-ium,7-bis(ethylamino)-2,8-dimethyl-, chloride
1934-16-3
new methylene blue n
nsc-9605
phenothiazin-5-ium, 3,7-bis(ethylamino)-2,8-dimethyl-, chloride
basic blue 24
SCHEMBL220238
AKOS024287626
phenothiazin-5-ium, 3,7-bis(ethylamino)-2,8-dimethyl-, chloride (1:1)
ci 52030
c.i. 52030
DTXSID30894752
Q8214050
ethyl-[7-(ethylamino)-2,8-dimethylphenothiazin-3-ylidene]azanium;chloride
D91677

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (23.68)18.7374
1990's4 (10.53)18.2507
2000's6 (15.79)29.6817
2010's15 (39.47)24.3611
2020's4 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 38.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index38.14 (24.57)
Research Supply Index3.74 (2.92)
Research Growth Index4.93 (4.65)
Search Engine Demand Index62.15 (26.88)
Search Engine Supply Index2.41 (0.95)

This Compound (38.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.50%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other39 (97.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]